53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2019
Source ID
10.1016/j.ygyno.2019.01.015

Entities

People

  • Agnes Jager
  • Andrea E. Wahner Hendrickson
  • Ann L Oberg
  • Carla D. Van Herpen
  • Daniel W. Visscher
  • Elizabeth M Swisher
  • Jill M. Wagner
  • Jourik A. Gietema
  • Karen S. Flatten
  • Krista M. Goergen
  • Maja J.a. De Jonge
  • Maria I. Harrell
  • Martha W. Den Hollander
  • Matthew Dudley
  • Matthew J. Maurer
  • Peter Ansell
  • Rachel M. Hurley
  • Rutger H.t. Koornstra
  • Scott H Kaufmann
  • Stacie P. Shepherd
  • Vivian Negron
  • X. Wei Meng

Organizations

  • American Association for Cancer Research
  • Entertainment Industry Foundation
  • Mayo Foundation for Medical Education and Research
  • National Institutes of Health
  • National Ovarian Cancer Coalition
  • Stand Up to Cancer
  • United States Department of Defense